Practical closed-loop insulin delivery. A system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics.

We evaluated a practical closed-loop system of insulin delivery consisting of hourly blood glucose determinations using glucose oxidase reagent strips and an intravenous infusion of insulin controlled by a commonly available controller. In 25 insulin-dependent diabetic subjects, this system was successful in achieving and maintaining near euglycemia (blood glucose, 101 +/- 2 mg/dL, mean +/- SE) in the fasting state between 0200 and 0800 hours. This system may be useful in the management of insulin-dependent diabetic patients in various hospital settings. Also, in 10 subjects treated subsequently using a continuous subcutaneous insulin infusion, the mean hourly insulin infusion rate using the described system correlated well (r = 0.92) with the optimal overnight basal rate needed during continous subcutaneous insulin infusion therapy.

[1]  N. White,et al.  Reversal of Abnormalities in Ocular Fluorophotometry in Insulin-dependent Diabetes After Five to Nine Months of Improved Metabolic Control , 1982, Diabetes.

[2]  W Zingg,et al.  Clinical Control of Diabetes by the Artificial Pancreas , 1974, Diabetes.

[3]  W. Clarke,et al.  Failure of Cortisol Blockade to Inhibit Early Morning Increases in Basal Insulin Requirements in Fasting Insulin-dependent Diabetics , 1980, Diabetes.

[4]  A. Schiffrin,et al.  Improved Control in Diabetes with Continuous Subcutaneous Insulin Infusion , 1980, Diabetes Care.

[5]  A H Clemens,et al.  Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. , 1980, The New England journal of medicine.

[6]  M. Frais,et al.  Angina pectoris precipitated by unheated water mattresses. , 1981, The New England journal of medicine.

[7]  W. Clarke,et al.  Clinical evaluation and preliminary studies on the use of an artificial pancreatic beta cell in juvenile diabetes mellitus. , 1977, The Journal of pediatrics.

[8]  W. Tamborlane,et al.  Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system. , 1980, The American journal of medicine.

[9]  M. Buysschaert,et al.  Use of an artificial pancreas as a tool to determine subcutaneous insulin doses in juvenile diabetes , 1979, Diabetes Care.

[10]  K. Alberti,et al.  Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption. , 1981, British medical journal.

[11]  W. Clarke,et al.  Studies with a pancreatic beta cell simulator in the third trimester of pregnancies complicated by diabetes. , 1978, American journal of obstetrics and gynecology.

[12]  W. Tamborlane,et al.  Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. , 1979, The New England journal of medicine.

[13]  N. White,et al.  Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin. , 1981, The New England journal of medicine.

[14]  N. Rodger,et al.  Continuous Subcutaneous Infusion of Insulin in the Management of Diabetes Mellitus , 1980, Diabetes.

[15]  A H Clemens,et al.  Closed-loop and Open-loop Devices for Blood Glucose Control in Normal and Diabetic Subjects , 1978, Diabetes.

[16]  W. Clarke,et al.  Overnight Basal Insulin Requirements in Fasting Insulin-dependent Diabetics , 1980, Diabetes.